A detailed history of Deka Bank Deutsche Girozentrale transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 49,500 shares of JANX stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,500
Previous 49,500 -0.0%
Holding current value
$2.49 Million
Previous $1.88 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

BUY
$9.52 - $15.65 $471,240 - $774,675
49,500 New
49,500 $566,000
Q1 2022

Apr 28, 2022

SELL
$13.24 - $20.24 $595,800 - $910,799
-45,000 Closed
0 $0
Q4 2021

Feb 02, 2022

BUY
$15.44 - $27.32 $694,800 - $1.23 Million
45,000 New
45,000 $892,000

Others Institutions Holding JANX

About Janux Therapeutics, Inc.


  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $2.1B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.